Mikhail V. Blagosklonny, MD PhD, is a Boston-based oncology professor and Editor-in-Chief of leading journals focused on aging research. He is noted for pioneering work on rapamycin's potential to extend lifespan and the hyperfunction theory of aging, alongside contributions toward near-curing incurable cancers. His leadership in scientific publishing and research advances has established him as an expert in oncology and gerontology.

‌